Celgene Corporation (CELG) Call Buyers Still Waiting for a Breakout

Celgene Corporation (NASDAQ:CELG) isn't moving much, despite the firm's agreement to collaborate with Juno Therapeutics Inc (NASDAQ:JUNO) on immunotherapy research

by Alex Eppstein

    Published on Jun 30, 2015 at 3:00 PM

    Celgene Corporation (NASDAQ:CELG) is sitting out the rally among biopharmaceutical stocks, despite the company inking a 10-year deal with Juno Therapeutics Inc (NASDAQ:JUNO) to develop immunotherapy treatments. Specifically, while JUNO has surged over 16%, CELG is up a mere 0.6% at $115.57 -- disappointing news for option bulls.

    During the last four weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), traders have bought to open 2.44 CELG calls for every put. To put that in perspective, the ratio was a more modest 1.45 at the end of May. In other words, bullish betting has picked up in recent weeks.

    The brokerage bunch is also exceedingly optimistic. Thirteen analysts currently rate CELG a "buy" or better, compared to three "holds" and not a single "sell." Plus, the stock's consensus 12-month price target of $137.15 stands in never-before-seen territory.

    On the charts, Celgene Corporation (NASDAQ:CELG) has struggled to break out of the $120-$122 neighborhood in recent months. Along similar lines, the stock has given back 10.5% since touching a record high of $129.06 in late March -- though it's currently found a foothold atop its 40-day moving average, located at $114.24.

    A Schaeffer's exclusive!

    The Expert's Guide

    Access your FREE trading earning announcements before it's too late!


     
     

    Partnercenter


    NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

    MORE | MARKETstories


    Look Who's Going Bankrupt Next in America
    Porter Stansberry is making a concerning prediction.
    CE Stock Heading into Bullish Month
    Celanese stock is coming off a free fall from its all-time-high in late 2019
    HD Stock Sinks on Bear Notes, In-Store Changes
    Home Depot stock received price target cuts after sharing in-store changes
    Look Who's Going Bankrupt Next in America
    Porter Stansberry is making a concerning prediction.